Financhill
Back

Cellectar Biosciences Stock Predictions

Cellectar Biosciences Stock Forecast

  • Is Cellectar Biosciences Stock Undervalued?
    The current Cellectar Biosciences [CLRB] share price is $0.26. The Score for CLRB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CLRB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Cellectar Biosciences Stock Go Up Next Year?

Data Unavailable

Cellectar Biosciences Stock Rating

Data Unavailable

Cellectar Biosciences Stock Price History

Is CLRB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cellectar.com

52-Week Data

52-Week High:
4.45
52-Week Low:
0.25

Prediction Charts

Market Cap:
10.9M
Price in USD:
0.26
Volume:
11.49M
Beta:
0.83

Technical Analysis

SMA50:
1.82
SMA100:
1.96
SMA200:
2.60
52-Wk Change:
-89.92%

Stock Predictions

  • Is Cellectar Biosciences stock public?
    Yes, Cellectar Biosciences is a publicly traded company.
  • What is the Cellectar Biosciences stock quote today?
    The Cellectar Biosciences stock price is 0.26 USD today.
  • How to buy Cellectar Biosciences stock online?
    You can buy Cellectar Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-22 1.56 1.58 1.61 1.52
Nov-25 1.62 1.57 1.63 1.52
Nov-26 1.58 1.56 1.62 1.54
Nov-27 1.57 1.53 1.61 1.53
Nov-29 1.56 1.54 1.58 1.53
Dec-2 1.56 1.52 1.56 1.49
Dec-3 1.53 1.46 1.53 1.43
Dec-4 1.48 1.47 1.48 1.42
Dec-5 1.49 1.36 1.49 1.36
Dec-6 1.37 1.39 1.41 1.36
Dec-9 1.39 1.35 1.39 1.33
Dec-10 1.35 1.28 1.37 1.26
Dec-11 0.43 0.31 0.46 0.28
Dec-12 0.30 0.26 0.31 0.25

Cellectar Biosciences Earnings

Data Unavailable

Cellectar Biosciences Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.81 per share.

* Cellectar Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.